Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Supplement—October 2024
SUPPLEMENT ISSUE
Articles

Next-Generation Sequencing and Bioinformatics Consortium Approach to Genomic Surveillance

Lindsay C. Morton1Comments to Author , Nazia Rahman1, and Kimberly A. Bishop-Lilly1
Author affiliation: Cherokee Nation Strategic Programs, Tulsa, Oklahoma, USA (L.C. Morton, N. Rahman); Global Emerging Infections Surveillance Branch, Silver Spring, Maryland, USA (L.C. Morton, N. Rahman); Naval Medical Research Command Biological Defense Research Directorate, Fort Detrick, Maryland, USA (K.A. Bishop-Lilly)

Main Article

Figure

Tiered sequencing and bioinformatics capabilities for genomic surveillance within the US DoD. Modified from (15). DoD, Department of Defense; GEIS, Global Emerging Infections Surveillance.

Figure. Tiered sequencing and bioinformatics capabilities for genomic surveillance within the US DoD. Modified from (15). DoD, Department of Defense; GEIS, Global Emerging Infections Surveillance.

Main Article

References
  1. The White House. Addressing the threat of emerging infectious diseases [cited 2024 Mar 21]. https://clintonwhitehouse4.archives.gov/WH/EOP/OSTP/Security/html/whfactsht.html
  2. Rothberg  JM, Leamon  JH. The development and impact of 454 sequencing. Nat Biotechnol. 2008;26:1117–24. DOIPubMedGoogle Scholar
  3. Maljkovic Berry  I, Melendrez  MC, Bishop-Lilly  KA, Rutvisuttinunt  W, Pollett  S, Talundzic  E, et al. Next generation sequencing and bioinformatics methodologies for infectious disease research and public health: approaches, applications, and considerations for development of laboratory capacity. J Infect Dis. 2020;221(Suppl 3):S292–307.PubMedGoogle Scholar
  4. Frey  KG, Herrera-Galeano  JE, Redden  CL, Luu  TV, Servetas  SL, Mateczun  AJ, et al. Comparison of three next-generation sequencing platforms for metagenomic sequencing and identification of pathogens in blood. BMC Genomics. 2014;15:96. DOIPubMedGoogle Scholar
  5. Diao  Z, Han  D, Zhang  R, Li  J. Metagenomics next-generation sequencing tests take the stage in the diagnosis of lower respiratory tract infections. J Adv Res. 2021;38:201–12. DOIPubMedGoogle Scholar
  6. Simmonds  P, Adams  MJ, Benkő  M, Breitbart  M, Brister  JR, Carstens  EB, et al. Consensus statement: Virus taxonomy in the age of metagenomics. Nat Rev Microbiol. 2017;15:161–8. DOIPubMedGoogle Scholar
  7. Bennett  AJ, Paskey  AC, Ebinger  A, Pfaff  F, Priemer  G, Höper  D, et al. Relatives of rubella virus in diverse mammals. Nature. 2020;586:424–8. DOIPubMedGoogle Scholar
  8. Fries  AC, Gruner  W, Hanson  J. Sampling considerations for detecting genetic diversity of influenza viruses in the DoD Global Respiratory Pathogen Surveillance Program. MSMR. 2018;25:16–21.PubMedGoogle Scholar
  9. Lesho  E, Clifford  R, Onmus-Leone  F, Appalla  L, Snesrud  E, Kwak  Y, et al. The challenges of implementing next generation sequencing across a large healthcare system, and the molecular epidemiology and antibiotic susceptibilities of carbapenemase-producing bacteria in the healthcare system of the U.S. Department of Defense. PLoS One. 2016;11:e0155770. DOIPubMedGoogle Scholar
  10. Lesho  EP, Waterman  PE, Chukwuma  U, McAuliffe  K, Neumann  C, Julius  MD, et al. The antimicrobial resistance monitoring and research (ARMoR) program: the US Department of Defense response to escalating antimicrobial resistance. Clin Infect Dis. 2014;59:390–7. DOIPubMedGoogle Scholar
  11. US Department of Defense. Fiscal year (FY) 2019 budget estimates [cited 2024 Jan 12]. https://comptroller.defense.gov/Portals/45/Documents/defbudget/fy2019/budget_justification/pdfs/02_Procurement/01_CBDP_FY19_PB-Procurement_Exhibits.pdf
  12. US Department of Defense. DOD INSTRUCTION 6000.11 PATIENT MOVEMENT (PM). 2018 [cited 2024 Feb 27]. https://www.esd.whs.mil/Portals/54/Documents/DD/issuances/dodi/600011p.pdf?ver=2018-06-29-125141-720
  13. Illumina. Illumina sequencing platforms [cited 2024 Feb 25]. https://www.illumina.com/systems/sequencing-platforms.html
  14. Nanopore Technologies. Sequencing devices [cited 2024 Feb 25]. https://nanoporetech.com/products/sequence
  15. Maljkovic Berry  I, Rutvisuttinunt  W, Voegtly  LJ, Prieto  K, Pollett  S, Cer  RZ, et al. A Department of Defense Laboratory Consortium approach to next generation sequencing and bioinformatics training for infectious disease surveillance in Kenya. Front Genet. 2020;11:577563. DOIPubMedGoogle Scholar
  16. Velasco  JM, Navarro  FC, Diones  PC, Villa  V, Valderama  MT, Tabinas  H, et al. SARS-CoV-2 among military and civilian patients, metro Manila, Philippines. Mil Med. 2021;186:e760–6. DOIPubMedGoogle Scholar
  17. US Department of Defense. SARS-CoV-2 whole genome sequencing action plan for the Department of Defense Military Health System [cited 2024 Feb 27]. https://carepoint.health.mil/sites/AFHSB/geis/programmatics/ngsbc/SC2WGS/Documents/(CATMS1)%20TAB%20B%20-%20SARS-CoV-2%20WGS%20Expansion%20Action%20Plan%20-%20UPR002841-21.pdf
  18. Morton  L, Forshey  B, Bishop-Lilly  K, Cer  R, Fries  A, Bogue  A, et al. Establishment of SARS-CoV-2 genomic surveillance within the Military Health System during 1 March-31 December 2020. MSMR. 2022;29:11–8.PubMedGoogle Scholar
  19. Waitumbi  JN, Omuseni  E, Nyataya  J, Masakhwe  C, Sigei  F, Lemtudo  A, et al. COVID-19 mass testing and sequencing: Experiences from a laboratory in Western Kenya. Afr J Lab Med. 2022;11:1737. DOIPubMedGoogle Scholar
  20. Kimita  G, Nyataya  J, Omuseni  E, Sigei  F, Lemtudo  A, Muthanje  E, et al. Temporal lineage replacements and dominance of imported variants of concern during the COVID-19 pandemic in Kenya. Commun Med (Lond). 2022;2:103. DOIPubMedGoogle Scholar
  21. Larson  D, Brodniak  SL, Voegtly  LJ, Cer  RZ, Glang  LA, Malagon  FJ, et al. A case of early reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2021;73:e2827–8. DOIPubMedGoogle Scholar
  22. Thommana  A, Shakya  M, Gandhi  J, Fung  CK, Chain  PSG, Maljkovic Berry  I, et al. Intrahost SARS-CoV-2 k-mer Identification Method (iSKIM) for rapid detection of mutations of concern reveals emergence of global mutation patterns. Viruses. 2022;14:2128. DOIPubMedGoogle Scholar
  23. Lizewski  RA, Sealfon  RSG, Park  SW, Smith  GR, Porter  CK, Gonzalez-Reiche  AS, et al. SARS-CoV-2 outbreak dynamics in an isolated US military recruit training center with rigorous prevention measures. Epidemiology. 2022;33:797–807. DOIPubMedGoogle Scholar
  24. Hakre  S, Maljkovic-Berry  I, Hang  J, Conte  MA, Pollio  AR, Fung  CK, et al. Transmission of SARS-CoV-2 among recruits in a US Army training environment: a brief report. J Public Health (Oxf). 2023;45:748–52. DOIPubMedGoogle Scholar
  25. Cer  RZ, Voegtly  LJ, Adhikari  BN, Pike  BL, Lueder  MR, Glang  LA, et al. Genomic and virologic characterization of samples from a shipboard outbreak of COVID-19 reveals distinct variants within limited temporospatial parameters. Front Microbiol. 2022;13:960932. DOIPubMedGoogle Scholar
  26. Maljkovic Berry  I, Hang  J, Fung  C, Yang  Y, Chibucos  M, Pollio  A, et al. Genomic surveillance of SARS-CoV-2 in US military compounds in Afghanistan reveals multiple introductions and outbreaks of Alpha and Delta variants. BMC Genomics. 2022;23:513. DOIPubMedGoogle Scholar
  27. Hakre  S, Lam  EY, Maljkovic-Berry  I, Hang  J, Pow Sang  LA, Bianchi  EJ, et al. Investigation of an outbreak of COVID-19 among U.S. military personnel and beneficiaries stationed in the Republic of Korea, June-July 2021. PLOS Glob Public Health. 2022;2:e0000236. DOIPubMedGoogle Scholar
  28. Arnold  CE, Voegtly  LJ, Stefanov  EK, Lueder  MR, Luquette  AE, Miller  RH, et al. SARS-CoV-2 infections in vaccinated and unvaccinated populations in Camp Lemonnier, Djibouti, from April 2020 to January 2022. Viruses. 2022;14:1918. DOIPubMedGoogle Scholar
  29. Servies  TE, Larsen  EC, Lindsay  RC, Jones  JS, Cer  RZ, Voegtly  LJ, et al. Notes from the field: outbreak of COVID-19 among a highly vaccinated population aboard a U.S. Navy ship after a port visit—Reykjavik, Iceland, July 2021. MMWR Morb Mortal Wkly Rep. 2022;71:279–81. DOIPubMedGoogle Scholar
  30. Smith  DR, Singh  C, Green  J, Lueder  MR, Arnold  CE, Voegtly  LJ, et al. Genomic and virological characterization of SARS-CoV-2 variants in a subset of unvaccinated and vaccinated U.S. military personnel. Front Med (Lausanne). 2022;8:836658. DOIPubMedGoogle Scholar
  31. US Department of Defense. 2023 Biodefense posture review [cited 2024 Feb 27]. https://media.defense.gov/2023/Aug/17/2003282337/-1/-1/1/2023_BIODEFENSE_POSTURE_REVIEW.PDF
  32. Morton  L, Creppage  K, Rahman  N, Early  J, Hartman  L, Hydrick  A, et al. Challenges and opportunities in pathogen agnostic sequencing for public health surveillance: lessons learned from the global emerging infections surveillance program. Health Secur. 2023.PubMedGoogle Scholar
  33. Boddie  C, Watson  M, Sell  TK. Federal funding for health security in FY2017. Health Secur. 2016;14:284–304. DOIPubMedGoogle Scholar

Main Article

1These authors contributed equally to this article.

Page created: October 30, 2024
Page updated: November 11, 2024
Page reviewed: November 11, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external